Cannabis Withdrawal Syndrome

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

Plain-language summary

If you use cannabis heavily and daily and then stop, there's a real chance you'll feel bad for a week or two. This isn't in your head and it isn't weakness. The most common symptoms are irritability, anxiety, sleep problems (including vivid dreams), decreased appetite, restlessness, and a depressed mood. Physical symptoms like sweating, chills, headache, and stomach pain also happen but are usually milder Strong evidence^[1][2].

Roughly half of people who try to quit after heavy regular use experience clinically meaningful withdrawal Strong evidence^[3]. Symptoms typically start within 24–72 hours, peak in the first week, and mostly resolve within two weeks — though sleep disruption can linger for a month or more Strong evidence^[1][4].

Unlike alcohol or benzodiazepine withdrawal, cannabis withdrawal is not medically dangerous. Nobody has seizures. Nobody dies from it. But it is uncomfortable enough that it drives a lot of relapse, which is the main clinical reason it matters Strong evidence^[2][5].

This article is not medical advice. If you are trying to quit and struggling, talk to a clinician — especially if you have co-occurring depression, anxiety, or another substance use disorder.

What probably works

Cognitive behavioral therapy (CBT), motivational enhancement therapy (MET), and contingency management. These are the best-supported interventions for cannabis use disorder and, indirectly, for getting through withdrawal without relapse Strong evidence^[6]. A Cochrane meta-analysis of psychosocial interventions found combined CBT+MET+contingency management produced the biggest reductions in frequency of use and increased abstinence rates compared to control or single-therapy approaches Strong evidence^[6].

Expectation-setting about the withdrawal timeline. Knowing that symptoms peak around day 2–6 and fade by week 2 is protective. People who understand what to expect are less likely to relapse to 'fix' what they assume is a permanent problem Strong evidence^[1].

Sleep hygiene basics — consistent wake time, morning light, limiting late caffeine, avoiding screens in bed — help with the insomnia that's often the worst and longest-lasting symptom Weak / limited. No randomized controlled trials specific to cannabis withdrawal, but low-risk and inexpensive.

Agonist substitution with dronabinol (oral THC) or nabiximols (THC:CBD oral spray). These reduce withdrawal severity in both inpatient and outpatient trials Strong evidence^[7][8]. However, they do not reliably increase long-term abstinence Strong evidence^[7][8]. Think of them like nicotine replacement: useful for the acute discomfort, not a cure. They require medical supervision and are most appropriate in structured outpatient or inpatient settings.

What might work

Gabapentin. Showed reduced withdrawal symptoms and improved abstinence in a small (n=50) placebo-controlled trial at 1200 mg/day Weak / limited^[9]. Promising signal but not yet replicated at scale. Further research needed before clinical recommendation.

N-acetylcysteine (NAC). Showed benefit in cannabis-dependent adolescents in one trial Weak / limited^[10] but failed to replicate in adults in a larger multi-site trial Weak / limited^[11]. Currently Disputed, leaning negative for adults.

Exercise. Small studies suggest aerobic exercise reduces craving and use in cannabis-dependent adults Weak / limited^[12]. Plausible mechanism, low risk, but limited evidence base. May also help with mood and sleep.

CBD (cannabidiol). A 2020 phase 2a trial found 400 mg and 800 mg daily CBD reduced cannabis use in people with cannabis use disorder Weak / limited^[13]. Interesting signal but needs replication and longer follow-up. Dose and optimal formulation are unclear.

Cannabinoid FAAH inhibitors (e.g., PF-04457845). Showed reduced withdrawal symptoms in one trial Weak / limited^[14] but development has been slow and safety concerns from unrelated FAAH inhibitors (including the discontinued BIA 10-2474) dampened further investigation in humans Weak / limited^[14].

What doesn't work or shows weak evidence

Bupropion. A controlled trial found it did not reduce withdrawal and may have worsened irritability and sleep Strong evidence^[15]. Not recommended.

Quetiapine (an antipsychotic). Reduced some withdrawal symptoms but increased cannabis craving and use in an outpatient trial — a net harmful tradeoff Strong evidence^[16]. Not recommended.

Naltrexone. Mixed and generally disappointing results for cannabis use disorder Weak / limited. Not standard treatment.

'Tapering' by switching to CBD-only flower, kratom, or kava. No controlled evidence any of these help with cannabis withdrawal specifically No data. Popular on forums and in peer support but not studied in rigorous trials.

Detox teas, 'THC flushes,' and commercial cleanse products. These are marketed to accelerate elimination or "flush" THC from the body but target drug-test detection, not withdrawal symptoms, and don't reliably achieve either goal No data.

Going back to smaller amounts of cannabis to 'taper.' No RCT evidence this works better than abrupt cessation, and it prolongs exposure to the reinforcer and delays recovery No data. This differs from clinician-supervised agonist substitution with dronabinol or nabiximols, which uses standardized pharmacotherapy.

What we don't know

• Why some heavy users get severe withdrawal and others get almost none. Genetics, baseline anxiety, CB1 receptor downregulation, and cannabis use history all probably matter, but no clinically useful predictive test exists.
• Whether high-potency concentrates (dabs, vapes at 70–90% THC) produce a distinct or more severe withdrawal syndrome than lower-potency flower. Clinically it looks worse, but rigorous comparative data are sparse Weak / limited.
• Long-term trajectory of protracted symptoms (sleep, mood) beyond 30 days. Most clinical trials end at 4 weeks; longer follow-up data are limited.
• Whether CBD, at what dose, and in what formulation actually helps, or is a novel placebo effect. The Freeman 2020 trial is encouraging but a single study.
• Optimal treatment for adolescents, who have different developmental neurobiology and may metabolize cannabinoids differently than adults.
• Whether medical cannabis patients using cannabis for pain, PTSD, or sleep experience withdrawal differently from recreational users when tapering, or whether underlying conditions rebound differently.

Comparison with other substance withdrawal syndromes

Cannabis withdrawal sits closest to nicotine in severity and risk profile: uncomfortable, drives relapse, but not medically dangerous Strong evidence^[1][2]. The clinical gap is that nicotine has three FDA-approved pharmacotherapies and cannabis has zero — only off-label or investigational agents show promise.

Risks and when to seek help

The main risk of cannabis withdrawal isn't the withdrawal itself — it's relapse and worsening of underlying mental health conditions.

• Suicidal ideation can emerge or worsen during withdrawal, especially in people with prior depression or other psychiatric conditions Strong evidence^[17]. This is a compelling reason to seek professional help, not push through alone.
• Anxiety and panic can spike acutely, and people sometimes reach for alcohol, benzodiazepines, or other drugs to cope — creating a new dependency or worsening problem.
• Sleep deprivation from prolonged insomnia can impair driving, work performance, and judgment.
• People using cannabis to self-manage PTSD, chronic pain, nausea, or other medical conditions may see those underlying symptoms rebound hard during withdrawal.

Seek professional help if:

• Symptoms are severe or disabling
• You have suicidal thoughts or ideation
• You have co-occurring substance use (alcohol, opioids, benzodiazepines)
• You've tried to quit multiple times and can't stay abstinent
• You're using cannabis to manage a diagnosed medical or psychiatric condition
• Sleep disruption or mood changes are affecting your ability to function or your safety

SAMHSA's National Helpline (1-800-662-4357, US) is free, confidential, and available 24/7. Your doctor or a local addiction medicine specialist can also offer assessment and tailored treatment.

This article is not medical advice. It is educational information about withdrawal and evidence for interventions. Talk to a licensed clinician about your specific situation, especially if you have underlying psychiatric conditions or are taking other medications.

Sources

How this page was made

Related

• Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
• Cannabis Withdrawal and Sleep Disruption — Sleep disruption is a hallmark of cannabis withdrawal syndrome and typically resolves with...
• THC Dose and Anxiety — Low doses may reduce acute anxiety; higher doses increase it. Evidence is limited, risks a...